MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process

Using artificial intelligence to enhance data on clinical trial outcomes can help biomedical firms, investors, and — ultimately — patients.

An interactive corporate dataset, an AI ethicist, marketing strategies, and more.

A debate on whether machines should pay up for replacing human workers.